Toby Maher joins the Scientific Advisory Board

Prof. Toby Maher, interstitial lung disease specialist at USC and Imperial College London, joined the Neotis Scientific Advisory Board.

He has run over 100 clinical trials in idiopathic pulmonary fibrosis and related interstitial lung diseases, bringing direct trial design and clinical development experience to the lead programme.